Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Mausam Patel

Concepts (56)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Scalp
1
2024
40
0.920
Why?
Brachytherapy
2
2020
48
0.900
Why?
SEER Program
5
2020
94
0.860
Why?
Glioblastoma
1
2022
92
0.760
Why?
Neoplasm Micrometastasis
1
2020
7
0.710
Why?
Urethral Neoplasms
1
2019
6
0.690
Why?
Adenocarcinoma, Clear Cell
1
2019
34
0.680
Why?
Brain Neoplasms
1
2022
287
0.660
Why?
Carcinoma, Signet Ring Cell
1
2018
14
0.650
Why?
Carcinoma, Non-Small-Cell Lung
1
2020
154
0.630
Why?
Prostatic Neoplasms
1
2020
394
0.550
Why?
Adenocarcinoma
1
2020
396
0.550
Why?
Pancreatic Neoplasms
1
2018
208
0.540
Why?
Lung Neoplasms
1
2020
606
0.480
Why?
Survival Rate
3
2020
894
0.430
Why?
Aged
6
2024
9310
0.370
Why?
Breast Neoplasms
1
2020
1174
0.370
Why?
Radiotherapy, Adjuvant
2
2020
56
0.360
Why?
Kaplan-Meier Estimate
2
2022
466
0.360
Why?
Aged, 80 and over
4
2024
3129
0.340
Why?
Survival Analysis
2
2022
653
0.340
Why?
Neoplasm Staging
2
2020
740
0.290
Why?
United States
4
2022
4860
0.290
Why?
Combined Modality Therapy
2
2019
637
0.290
Why?
Retrospective Studies
4
2024
6108
0.270
Why?
Middle Aged
5
2024
12069
0.260
Why?
Humans
10
2024
49974
0.250
Why?
Adult
5
2024
13236
0.250
Why?
Radiation Oncology
1
2023
23
0.230
Why?
Anticonvulsants
1
2022
121
0.200
Why?
Female
6
2024
26472
0.190
Why?
Male
5
2024
25241
0.190
Why?
Head and Neck Neoplasms
1
2024
268
0.190
Why?
Medicare
1
2022
246
0.190
Why?
Patents as Topic
1
2020
8
0.180
Why?
Industry
1
2020
17
0.180
Why?
Inventions
1
2020
9
0.180
Why?
Neoplasm Recurrence, Local
1
2024
614
0.180
Why?
Disease-Free Survival
1
2020
454
0.170
Why?
Propensity Score
1
2020
123
0.170
Why?
Proportional Hazards Models
1
2020
402
0.170
Why?
Mastectomy
1
2020
140
0.160
Why?
Universities
1
2020
161
0.160
Why?
Florida
1
2018
58
0.160
Why?
Internship and Residency
1
2023
443
0.150
Why?
Cohort Studies
1
2020
1422
0.140
Why?
Prognosis
1
2018
1942
0.110
Why?
Follow-Up Studies
1
2018
2182
0.110
Why?
Young Adult
1
2018
3958
0.080
Why?
Treatment Outcome
1
2019
5141
0.080
Why?
Adolescent
1
2018
6356
0.070
Why?
Faculty
1
2023
72
0.060
Why?
Radiotherapy Dosage
1
2024
244
0.060
Why?
Educational Status
1
2023
222
0.050
Why?
Radiotherapy, Intensity-Modulated
1
2024
172
0.050
Why?
Prospective Studies
1
2023
2364
0.040
Why?
Patel's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description